The Journal of Allergy and Clinical Immunology
Volume 94, Issue 4 , Pages 676-683 , October 1994

Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma

Received 14 April 1993 ,Revised 7 January 1994 ,Accepted 30 March 1994.

References 

  1. Chestnutt MS, Lazarus SC. Asthma therapy in the nineties: focus on inflammation. Hosp Formulary. 1992;27:466–482
  2. Sheffer AL. Guidelines for the diagnosis and management of asthma: National Heart, Lung, and Blood Institute, national asthma education program expert panel report. J Allergy Clin Immunol. 1991;88:425–534 (Suppl)
  3. Geddes DM. Inhaled corticosteroids: benefits and risks. Thorax. 1992;47:404–407
  4. Phillipps GH. Structure-activity relationships of topically active steroids: the selection of fluticasone propionate. Resp Med. 1990;84(Suppl A):19–23
  5. Harding SM. The human pharmacology of fluticasone propionate. Resp Med. 1990;84(Suppl A):25–29
  6. Barnes NC, Marone G, Di Maria GU, Visser S, Utama I, Payne SL. A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma. Eur Resp J. 1993;6:877–884
  7. Fabbri L, Burge PS, Croonenborgh L, et al.  Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. Thorax. 1993;48:817–823
  8. Gustafsson P, Tsanakas J, Gold M, Primhak R, Radford M, Gillies E. Comparison of the efficacy and safety of inhaled fluticasone propionate 200 mcg/day with inhaled beclomethasone dipropionate 400 mcg/day in mild and moderate asthma. Arch Dis Child. 1993;69:206–211
  9. Committee on Diagnostic Standards for Nontuberculosis Respiratory Diseases . Definitions and classification of chronic bronchitis, asthma and pulmonary emphysema. Am Rev Respir Dis. 1962;85:762–768
  10. Gaddie J, Reid IW, Skinner C, et al.  Aerosol beclomethasone dipropionate: a dose-response study in chronic bronchial asthma. Lancet. 1973;2:280–281
  11. Hummel S, Lehtonen L. Comparison of oral-steroid sparing by high-dose and low-dose inhaled steroid in maintenance treatment of severe asthma. Lancet. 1992;340:1483–1487
  12. Costello JF, Clarke TJH. Response of patients receiving high dose beclomethasone dipropionate. Thorax. 1974;29:571–573
  13. Toogood HJ, Lefcoe NM, Haines DSM, et al.  A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthma. J Allergy Clin Immunol. 1977;59:298–308
  14. Tarlo SM, Broder I, Davies GM, Leznoff A, Mintz S, Corey PN. Six-month double-blind, controlled trial of high dose, concentrated beclomethasone dipropionate in the treatment of severe chronic asthma. Chest. 1988;93:998–1002
  15. Williams AJ, Baghat MS, Stableforth DE, Cayton RM, Shenoi PM, Skinner C. Dysphonia caused by inhaled steroids: recognition of a characteristic laryngeal abnormality. Thorax. 1983;38:813–821

☆ This study was funded in part by Glaxo Research Institute.

PII: 0091-6749(94)90174-0

The Journal of Allergy and Clinical Immunology
Volume 94, Issue 4 , Pages 676-683 , October 1994

Article Tools